These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 19726087)

  • 1. Glycan bioengineering in immunogen design for tumor T antigen immunotargeting.
    Sendra VG; Zlocowski N; Ditamo Y; Copioli S; Tarp MP; Bennett EP; Clausen H; Roth GA; Nores GA; Irazoqui FJ
    Mol Immunol; 2009 Oct; 46(16):3445-53. PubMed ID: 19726087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune response to Thomsen-Friedenreich disaccharide and glycan engineering.
    Irazoqui FJ; Sendra VG; Lardone RD; Nores GA
    Immunol Cell Biol; 2005 Aug; 83(4):405-12. PubMed ID: 16033536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A fully synthetic vaccine consisting of a tumor-associated glycopeptide antigen and a T-cell epitope for the induction of a highly specific humoral immune response.
    Dziadek S; Hobel A; Schmitt E; Kunz H
    Angew Chem Int Ed Engl; 2005 Nov; 44(46):7630-5. PubMed ID: 16247815
    [No Abstract]   [Full Text] [Related]  

  • 4. Influence of terminal residue on adjacent disaccharide immunogenicity.
    Irazoqui FJ; Lopez PH; Mandel U; Nores GA
    Mol Immunol; 2002 Mar; 38(11):825-31. PubMed ID: 11922940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel immunogenicity of Thomsen-Friedenreich disaccharide obtained by a molecular rotation on its carrier linkage.
    Irazoqui FJ; Lopez PH; Vides MA; Nores GA
    Glycobiology; 2000 Aug; 10(8):781-7. PubMed ID: 10929004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of the Thomsen-Friedenreich antigen.
    MacLean GD; Longenecker BM
    Semin Cancer Biol; 1991 Dec; 2(6):433-9. PubMed ID: 1810470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunization with mimotopes prevents growth of carcinoembryonic antigen positive tumors in BALB/c mice.
    Brämswig KH; Knittelfelder R; Gruber S; Untersmayr E; Riemer AB; Szalai K; Horvat R; Kammerer R; Zimmermann W; Zielinski CC; Scheiner O; Jensen-Jarolim E
    Clin Cancer Res; 2007 Nov; 13(21):6501-8. PubMed ID: 17975163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction of human melanoma tumor growth in severe combined immunodeficient mice by passive transfer of antibodies induced by a high molecular weight melanoma-associated antigen mimotope vaccine.
    Wagner S; Krepler C; Allwardt D; Latzka J; Strommer S; Scheiner O; Pehamberger H; Wiedermann U; Hafner C; Breiteneder H
    Clin Cancer Res; 2008 Dec; 14(24):8178-83. PubMed ID: 19088033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The immunotargeting approach to adjuvant-independent subunit vaccine design.
    Barber BH
    Semin Immunol; 1997 Oct; 9(5):293-301. PubMed ID: 9327524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlative fine specificity of several Thomsen-Friedenreich disaccharide-binding proteins with an effect on tumor cell proliferation.
    Irazoqui FJ; Jansson B; Lopez PH; Nores GA
    J Biochem; 2001 Jul; 130(1):33-7. PubMed ID: 11432777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-traditional immunogens and their application to immunotherapy.
    Chatterjee M; Tainsky MA
    Curr Opin Mol Ther; 2008 Feb; 10(1):62-7. PubMed ID: 18228183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variable epitope library-based vaccines: shooting moving targets.
    Pedroza-Roldan C; Charles-Niño C; Saavedra R; Govezensky T; Vaca L; Avaniss-Aghajani E; Gevorkian G; Manoutcharian K
    Mol Immunol; 2009 Dec; 47(2-3):270-82. PubMed ID: 19853920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved efficacy of DNA vaccination against prostate carcinoma by boosting with recombinant protein vaccine and by introduction of a novel adjuvant epitope.
    Lu Y; Ouyang K; Fang J; Zhang H; Wu G; Ma Y; Zhang Y; Hu X; Jin L; Cao R; Fan H; Li T; Liu J
    Vaccine; 2009 Aug; 27(39):5411-8. PubMed ID: 19616501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunological response from an entirely carbohydrate antigen: design of synthetic vaccines based on Tn-PS A1 conjugates.
    De Silva RA; Wang Q; Chidley T; Appulage DK; Andreana PR
    J Am Chem Soc; 2009 Jul; 131(28):9622-3. PubMed ID: 19552408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opposite effects on human colon cancer cell proliferation of two dietary Thomsen-Friedenreich antigen-binding lectins.
    Yu LG; Milton JD; Fernig DG; Rhodes JM
    J Cell Physiol; 2001 Feb; 186(2):282-7. PubMed ID: 11169464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MMP11: a novel target antigen for cancer immunotherapy.
    Peruzzi D; Mori F; Conforti A; Lazzaro D; De Rinaldis E; Ciliberto G; La Monica N; Aurisicchio L
    Clin Cancer Res; 2009 Jun; 15(12):4104-13. PubMed ID: 19509157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential contributions of recognition factors of two plant lectins -Amaranthus caudatus lectin and Arachis hypogea agglutinin, reacting with Thomsen-Friedenreich disaccharide (Galbeta1-3GalNAcalpha1-Ser/Thr).
    Wu AM; Wu JH; Yang Z; Singh T; Goldstein IJ; Sharon N
    Biochimie; 2008; 90(11-12):1769-80. PubMed ID: 18809460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Towards a self-adjuvanting multivalent B and T cell epitope containing synthetic glycolipopeptide cancer vaccine.
    Renaudet O; BenMohamed L; Dasgupta G; Bettahi I; Dumy P
    ChemMedChem; 2008 May; 3(5):737-41. PubMed ID: 18205167
    [No Abstract]   [Full Text] [Related]  

  • 19. Engineering and biological characterization of VB6-845, an anti-EpCAM immunotoxin containing a T-cell epitope-depleted variant of the plant toxin bouganin.
    Cizeau J; Grenkow DM; Brown JG; Entwistle J; MacDonald GC
    J Immunother; 2009; 32(6):574-84. PubMed ID: 19483652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthetic vaccines consisting of tumor-associated MUC1 glycopeptide antigens and a T-cell epitope for the induction of a highly specific humoral immune response.
    Westerlind U; Hobel A; Gaidzik N; Schmitt E; Kunz H
    Angew Chem Int Ed Engl; 2008; 47(39):7551-6. PubMed ID: 18704911
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.